Who owns the RIPTAC trademark?

The RIPTAC trademark is owned by Halda Therapeutics OpCo, Inc..

What class is the RIPTAC trademark registered in?

The RIPTAC trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for RIPTAC?

The USPTO serial number for RIPTAC is 99107627.

What is the registration number for RIPTAC?

RIPTAC is registered under USPTO registration number 0.

Sealvo

Home Search: RIPTACRIPTAC #99107627

Back

Updated Oct 6, 2026·21 searches this week

View on USPTO TSDR Find similar marks

RIP

USPTO Trademark Record

PENDING

RIPTAC

SN 99107627·Reg 0·Filed Mar 27, 2025

Owner Halda Therapeutics OpCo, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

RIPTAC (Serial No. 99107627), Registration No. 0, is a pending US trademark filed on Mar 27, 2025 by Halda Therapeutics OpCo, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Statement of Use due: December 30, 202685 days remaining

Mark Intelligence

RIPTAC (Reg. #0) is a pending US trademark that was filed in 2025 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 27, 2025

SERIAL

99107627

REG#

Filing Information

StatusPENDING

Filing DateMar 27, 2025

Serial Number99107627

Registration No.0

Status DateJun 30, 2026

Published for OppositionMay 05, 2026

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

23 events

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 30, 2026

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

May 05, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 05, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 29, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 09, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Apr 02, 2026

TEAS CHANGE OF OWNER ADDRESS RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Apr 02, 2026

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Apr 02, 2026

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Apr 02, 2026

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 02, 2026

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Apr 02, 2026

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 25, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 25, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 25, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Nov 19, 2025

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Nov 19, 2025

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

ASSIGNED TO EXAMINER

Aug 26, 2025

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Aug 26, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Aug 26, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 26, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION ENTERED

Mar 27, 2025

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 27, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Mar 27, 2025

APPLICATION FILING RECEIPT MAILED

Other Marks by Halda Therapeutics OpCo, Inc.

Additional USPTO filings from the same owner.

HAL

HALDA THERAPEUTICS

97330340

Halda Therapeutics OpCo, Inc.

REGISTERED

HAL

HALDA

88625096

Halda Therapeutics OpCo, Inc.

REGISTERED

HAL

HALDA THERAPEUTICS

88625022

Halda Therapeutics OpCo, Inc.

REGISTERED

RIP

RIPTAC

97742256

Halda Therapeutics OpCo, Inc.

ABANDONED

Other Marks by Danielle Rivera

Additional USPTO filings handled by the same attorney of record.

LET

LET IN THE LYTE

97388270

REGISTERED

LOG

LogoMark

87907753

REGISTERED

INL

INLEXZO

98531370

REGISTERED

AUT

AUTOMATED IMPELLA CONTROLLER

97784229

REGISTERED

RIPTAC

Run a conflict check

Other Marks by Halda Therapeutics OpCo, Inc.

Other Marks by Danielle Rivera

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company